Reduced-toxicity conditioning regimen with low dose post-transplantation cyclophosphamide and low-dose anti-thymocyte globulin as graft-versus-host disease prophylaxis for haploidentical stem cell transplantation in older patients-Reference-Cited by-同舟云学术

Reduced-toxicity conditioning regimen with low dose post-transplantation cyclophosphamide and low-dose anti-thymocyte globulin as graft-versus-host disease prophylaxis for haploidentical stem cell transplantation in older patients

Published:2024-05-29 Issue:8 Volume:103 Page:3135-3143
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Ye Peipei,Wu Mengjie,Cao Junjie,Pei Renzhi,Yuan Jiaojiao,Zhuang Haihui,Fang Ying,Lu Ying

Funder

the Zhejiang Provincial Medical and Health Science and Technology Project

Ningbo Public Welfare Science and Technology Planning Project

Ningbo Clinical Research Center for Ophthalmology

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00277-024-05818-5.pdf

Reference53 articles.

1. Ustun C, Le-Rademacher J, Wang HL et al (2019) Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60–75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study. Leukemia 33:2599–2609. https://doi.org/10.1038/s41375-019-0477-x

2. Kanapuru B, Singh H, Kwitkowski V, Blumenthal G, Farrell AT, Pazdur R (2020) Older adults in hematologic malignancy trials: representation, barriers to participation and strategies for addressing underrepresentation. Blood Rev 43:100670. https://doi.org/10.1016/j.blre.2020.100670

3. Ciurea SO, Rodrigues M, Giralt S, de Lima M (2009) Aging, acute myelogenous leukemia, and allogeneic transplantation: do they belong in the same sentence? Clin Lymphoma Myeloma 9:289–297. https://doi.org/10.3816/CLM.2009.n.057

4. Kasamon YL, Bolanos-Meade J, Prince GT et al (2015) Outcomes of nonmyeloablative HLA-Haploidentical blood or marrow transplantation with high-dose Post-transplantation Cyclophosphamide in older adults. J Clin Oncol 33:3152–3161. https://doi.org/10.1200/JCO.2014.60.4777

5. Sun YQ, Han TT, Wang Y et al (2021) Haploidentical stem cell transplantation with a Novel Conditioning Regimen in older patients: a prospective single-arm phase 2 study. Front Oncol 11:639502. https://doi.org/10.3389/fonc.2021.639502